Medicare Enrolled
Dr. Aaron Bey, M.D.
Urology Physician · Cincinnati, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bey
Dr. Aaron Bey is an urology physician in Cincinnati, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Bey performed 3,912 Medicare services across 2,269 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bey received a total of $11,910 from 54 pharmaceutical and/or device companies across 468 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 11% volume in OH
$11,910 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,912
Medicare services
Top 11% in OH for urology physician
2,269
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~217 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,100 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
698 | $85 | $248 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
593 | $3 | $25 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
232 | $8 | $32 |
| PSA test (prostate cancer screening) | 215 | $18 | $71 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
130 | $44 | $206 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
128 | $7 | $94 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
101 | $109 | $392 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
62 | $55 | $623 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
52 | $23 | $312 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
51 | $18 | $85 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
51 | $20 | $51 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
50 | $40 | $2,513 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
34 | $8 | $57 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
31 | $39 | $112 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
29 | $8 | $39 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $53 | $193 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
27 | $25 | $101 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
25 | $90 | $1,285 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
24 | $8 | $105 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
24 | $8 | $105 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
23 | $566 | $2,319 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
23 | $17 | $80 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
21 | $309 | $2,307 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $90 | $547 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
19 | $582 | $3,081 |
| Total estradiol level test A blood test that measures the total amount of estradiol, a form of estrogen, in the body. |
19 | $27 | $115 |
| Complicated insertion of bladder tube | 17 | $111 | $429 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
16 | $118 | $1,734 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $70 | $289 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
15 | $114 | $893 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
13 | $163 | $3,278 |
| Liver function blood test panel | 12 | $8 | $47 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $103 | $316 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
33.3% medium
65.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,910
Total received (2018-2024)
Avg $1,701/year across 7 years
Top 14% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
468
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,517 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$393 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,627
2023
$1,868
2022
$1,516
2021
$1,588
2020
$1,155
2019
$1,916
2018
$1,240
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$467
Sumitomo Pharma America, Inc.
$395
Janssen Biotech, Inc.
$284
Dendreon Pharmaceuticals LLC
$171
UROGEN PHARMA, INC.
$158
Boston Scientific Corporation
$148
SRS Medical Systems, Inc.
$135
PROCEPT BioRobotics Corporation
$130
Laborie Medical Technologies Corp.
$113
Merck Sharp & Dohme LLC
$111
ABBVIE INC.
$96
Ferring Pharmaceuticals Inc.
$65
Tolmar, Inc.
$48
IMMUNITYBIO, INC.
$44
Bayer Healthcare Pharmaceuticals Inc.
$39
Antares Pharma, Inc.
$38
Novartis Pharmaceuticals Corporation
$32
Becton, Dickinson and Company
$29
ACCORD HEALTHCARE, INC.
$27
PROGENICS PHARMACEUTICALS, INC.
$22
Endo USA, Inc.
$22
Axonics, Inc.
$20
AngioDynamics, Inc.
$19
PFIZER INC.
$16
Top 3 companies account for 43.6% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$1,780
Teleflex LLC
$1,199
Astellas Pharma US Inc
$1,093
Janssen Biotech, Inc.
$840
Sumitomo Pharma America, Inc.
$621
PROCEPT BioRobotics Corporation
$617
Dendreon Pharmaceuticals LLC
$492
PFIZER INC.
$426
Axonics, Inc.
$351
Antares Pharma, Inc.
$332
UROGEN PHARMA, INC.
$302
Merck Sharp & Dohme LLC
$286
UroGen Pharma, Inc.
$280
Bayer HealthCare Pharmaceuticals Inc.
$275
Myovant Sciences Inc.
$239
AbbVie Inc.
$216
Axonics Modulation Technologies, Inc.
$183
Coloplast Corp
$178
Olympus America Inc.
$177
Boston Scientific Corporation
$169
SRS Medical Systems, Inc.
$135
ABBVIE INC.
$131
Blue Earth Diagnostics Limited
$125
UROVANT SCIENCES INC
$115
Laborie Medical Technologies Corp.
$113
AbbVie, Inc.
$112
TOLMAR Pharmaceuticals, Inc.
$109
Endo Pharmaceuticals Inc.
$100
Ferring Pharmaceuticals Inc.
$82
Acerus Pharmaceuticals Corporation
$78
Allergan, Inc.
$69
ACCORD HEALTHCARE, INC.
$68
Novartis Pharmaceuticals Corporation
$62
Bayer Healthcare Pharmaceuticals Inc.
$58
Calyxo, Inc.
$57
Progenics Pharmaceuticals, Inc.
$49
Tolmar, Inc.
$48
IMMUNITYBIO, INC.
$44
Clarus Therapeutics Inc.
$42
Becton, Dickinson and Company
$29
AstraZeneca Pharmaceuticals LP
$28
PROGENICS PHARMACEUTICALS, INC.
$22
Endo USA, Inc.
$22
AngioDynamics, Inc.
$19
Avadel Specialty Pharmaceuticals, LLC
$18
Alnylam Pharmaceuticals Inc.
$16
AXOGEN
$15
GENZYME CORPORATION
$14
CONMED Corporation
$14
Metuchen Pharmaceuticals
$13
Mission Pharmacal Company
$13
Kowa Pharmaceuticals America, Inc.
$12
COLOPLAST CORP
$12
Hollister Incorporated
$11
Top 3 companies account for 34.2% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AIRSEAL · AMS 700 · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ARISTA AH FlexiTip · Androgel · AquaBeam Robotic System · AxoGuard Nerve Protector · Axonics · Axonics r-SNM System · Axumin · BOTOX · CAMCEVI · CONTINENCE CARE · CT3000 Pro Base Unit · CVAC · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · Infyna Chic · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LYRICA · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PENILE & TESTICULAR RECONSTRUCTN · PLUVICTO · PROVENGE · PYLARIFY · SPEEDICATH · Seglentis · SpeediCath · Stendra · TITAN · TOVIAZ · UROLIFT · Uribel · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xofigo · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
79
Per 100K population
37.6
County median income
$83,178
Nearest hospital
MERCY HEALTH-ANDERSON HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bey is a clinical cardiology specialist, with above-average Medicare volume (top 11% in OH), with low-engagement industry engagement in the top 14% of OH peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bey experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Bey performed 1,100 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bey receive payments from pharmaceutical companies?
Yes. Dr. Bey received a total of $11,910 from 54 companies across 468 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bey's costs compare to other urology physicians in Cincinnati?
Dr. Bey's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Cincinnati
Browse urology physicians in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology